Related Experiment Video

Updated: May 21, 2026

Protein Transfection of Mouse Lung
04:21

Protein Transfection of Mouse Lung

Published on: May 15, 2013

Mitogen-activated protein kinase phosphatase 2, MKP-2, regulates early inflammation in acute lung injury

Timothy T Cornell1, Andrew Fleszar, Walker McHugh

  • 1Division of Pediatric Critical Care Medicine, Dept. of Pediatrics and Communicable Diseases, Univ. of Michigan Medical School, C S Mott Children's Hospital, Ann Arbor, MI 48109-0243, USA. ttcornel@med.umich.edu

American Journal of Physiology. Lung Cellular and Molecular Physiology
|June 12, 2012
PubMed

Insights

Dual-specificity phosphatase MKP-2 (mitogen-activated protein kinase phosphatase-2) dampens inflammation in acute lung injury (ALI). MKP-2 deficiency reduces lung inflammation without impairing bacterial clearance, suggesting therapeutic potential.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pulmonary Medicine

Background:

  • Acute lung injury (ALI) involves inflammation and neutrophil infiltration, driven by mitogen-activated protein kinase (MAPK) pathways.
  • Dual-specific phosphatases (DUSP) like MKP-2 regulate MAPK activity, but MKP-2's role in ALI is unknown.

Purpose of the Study:

  • To investigate the role of MKP-2 in regulating inflammation during acute lung injury.
  • To determine if MKP-2 deficiency impacts the lung's ability to clear bacterial pathogens.

Main Methods:

  • Utilized MKP-2-null mice and MKP-2 knockdown in murine macrophages.
  • Induced ALI using intratracheal lipopolysaccharide (LPS) and bacterial challenge.

Main Results:

  • MKP-2-null mice showed reduced proinflammatory cytokine production and neutrophil infiltration in LPS-induced ALI.
  • MKP-2 deficiency did not hinder bacterial clearance in mice challenged with gram-positive or gram-negative bacteria.
  • MKP-2 knockdown in macrophages attenuated inflammation and increased ERK phosphorylation and MKP-1 induction.

Conclusions:

  • MKP-2 plays a significant role in promoting lung inflammation during ALI.
  • Targeting MKP-2 may offer a therapeutic strategy to reduce ALI-associated inflammation while preserving host defense against pathogens.

More Related Videos

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...